Effect of Annonaceous Sp. Ethanolic Extract on Transforming Growth Factor- Β (TGF- Β) Expression on MCF-7 Cells Line
Abstract
Aims: To analyze effect of the Annonaceous sp. ethanolic extract to Transforming Growth Factor- β (TGF- β) expressions on MCF-7 cells line.
Methods: This experimental analytic study used Randomized Complete Block Design (RCBD) with three repetitions. The extract was dissolved in 1 ml of DMSO with a concentration of 0.1%. Furthermore, dilution was made with a dose of 0 µg / ml (K); 25 µg / ml (P1); 50 µg / ml (P2); 100 µg / ml (P3); 200 µg / ml (P4). MCF-7 cells line were cultured using RPMI 1640 Medium with 80 – 90% confluent. The ethanolic extract of Annonaceous sp. was exposed to MCF-7 cells for 48 hours. Analyze Transforming Growth Factor- β (TGF- β) level using ELISA Methods with λ=405 nm.
Results: The results of the ELISA analysis show that the ethanolic extract of Annonaceous sp. has a potential effect of decreasing TGF- β expression on the sample with treatment on some concentration (p< 0,05).
Conclusion: The ethanolic extract of Annonaceous sp. has shown the potential effect to decreased of TGF- β level on MCF-7 cells line
Keywords: Annonaceous sp ethanolic extract, TGF- β, MCF-7 cells line, anti-cancer
Keywords:
Annonaceous sp ethanolic extract, TGF- β, MCF-7 cells line, anti-cancerDOI
https://doi.org/10.22270/jddt.v11i6-S.5214References
Momenimovahed Z, Salehiniya H, "Epidemiological Characteristics of and Risk Factors for Breast Cancer in the World" Breast Cancer, 2019; 11:151-64. https://doi.org/10.2147/BCTT.S176070
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A, "Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries" CA Cancer J Clin, 2018; 68(6):394-424. https://doi.org/10.3322/caac.21492
WHO, "Who Report on Cancer", Geneva: World Health Organization; 2020.
Komite Penanggulangan Kanker Nasional, "Panduan Penatalaksanaan Kanker Payudara", Jakarta: Kementeri Kesehat RI; 2015.
WHO, "Breast cancer", Geneva: WHO; 2018.
Karsono R, Purwanto DJ, Haryono SJ, Karsono B, Sari L, Pratiwi Y, et al., "Preoperative Neoadjuvant Hormonal Therapy and Neoadjuvant Chemotherapy for Stage 3B and 4 Breast Cancer Patients in Dharmais Hospital-National Cancer Center, Indonesia: A Cohort Study" Indones J Cancer, 2019;12(4):109-15. https://doi.org/10.33371/ijoc.v12i4.604
Esquivel M, Ostoa-Saloma P, Palacios-Arreola MI, Nava-Castro KE, Castro JI, Morales-montor J, "The Role of Cytokines in Breast Cancer Development and Progression" J Interferon Cytokine Res, 2014; 35(1):1-16. https://doi.org/10.1089/jir.2014.0026
Kurnijasanti R, Hamid IS, Rahmawati K, "Efek Sitotoksik In Vitro dari Ekstrak Buah Mahkota Dewa (Phaleria macrocarpa) Terhadap Kultur Sel Kanker Mieloma" J Penelit Med Eksakta, 2008; 7(1):48-54.
Desai A, Qazi G, Ganju R, El-Tamer M, Singh J, Saxena A, et al., "Medicinal Plants and Cancer Chemoprevention" Curr Drug Metab, 2008: 9(7):581-91. https://doi.org/10.2174/138920008785821657
Sukohar A, Herawati H, Witarto AB, Setiawan, Wirakusumah FF, Sastramihardja HS, "Role of Chlorogenic Acid from Lampung Robusta Coffee Against Gene Expression of Mirna (Micro Rna) 146 A on Hepatocellular Carcinoma Cells" IJPRNS, 2013; 2(6):776-84.
Hamizah S, Roslida AH, Fezah O, Tan KL, Tor YS, Tan CI, "Chemopreventive potential of Annona muricata L leaves on chemically-induced skin papillomagenesis in mice" Asian Pacific J Cancer Prev, 2012; 13(6):2533-9. https://doi.org/10.7314/APJCP.2012.13.6.2533
El Tawil GA, Noaman EA, Askar MA, El Fatih NM, Mohamed HE, "Anticancer and Apoptogenic Effect of Graviola and Low-Dose Radiation in Tumor Xenograft in Mice" Integr Cancer Ther, 2020; 19:1-12. https://doi.org/10.1177/1534735419900930
Li N, Shi Z, Tang Y, Chen J, Li X, "Recent progress on the total synthesis of acetogenins from Annonaceae" Beilstein Journal of Organic Chemistry, 2008; 4(48):1-62. https://doi.org/10.3762/bjoc.4.48
González MC, Tormo JR, Bermejo A, Zafra-Polo MC, Estornell E, Cortes D, "Rollimembrin, a novel acetogenin inhibitor of mammalian mitochondrial complex I" Bioorganic Med Chem Lett, 1997; 7(9):1113-8. https://doi.org/10.1016/S0960-894X(97)00171-6
Longatto Filho A, Lopes JM, Schmitt FC, "Angiogenesis and Breast Cancer" J Oncol, 2010; 2010:1-7. https://doi.org/10.1155/2010/576384
Ferrara N, "Vascular endothelial growth factor" Arterioscler Thromb Vasc Biol, 2009; 29(6):789-91. https://doi.org/10.1161/ATVBAHA.108.179663
Brown KA, Aakre ME, Gorska AE, Price JO, Eltom SE, Pietenpol JA, et al., "Induction by transforming growth factor-β1 of epithelial to mesenchymal transition is a rare event in vitro" Breast Cancer Res, 2004; 6(3):215-31. https://doi.org/10.1186/bcr778
Wong YH, Chiu CC, Lin CL, Chen TS, Jheng BR, Lee YC, et al., "A New Era for Cancer Target Therapies: Applying Systems Biology and Computer-Aided Drug Design to Cancer Therapies" Current Pharmaceutical Biotechnology, 2016; 17(14):1246-67. https://doi.org/10.2174/1389201017666161019160606
Stegmeier F, Warmuth M, Sellers WR, Dorsch M, "Targeted Cancer Therapies in the Twenty-First Century: Lessons From Imatinib" Clin Pharmacol Ther, 2010; 87(5):543-52. https://doi.org/10.1038/clpt.2009.297
Muhartono, Subeki, Hanriko R "Mucoxin (Acetogenin) Reduces Proinflammatory Cytokines in Breast Cancer" Biomed Pharmacol J, 2019;12(1):479-83. https://doi.org/10.13005/bpj/1664
Mangal M, Imran Khan M, Mohan Agarwal S, "Acetogenins as Potential Anti-cancer Agents" Anticancer Agents Med Chem, 2015: 16(2):138-59. https://doi.org/10.2174/1871520615666150629101827
Drabsch Y, Ten Dijke P, "TGF-β signaling in breast cancer cell invasion and bone metastasis" J Mammary Gland Biol Neoplasia, 2011; 16(2):97-108. https://doi.org/10.1007/s10911-011-9217-1
Tyasmara A, Sandhika W, "Comparison of TNF-α and TGF-β Expression in Breast Cancer Tissues-with and without Axillary Lymph Node Metastasis" Indones J Cancer, 2018;12(1):1-5 https://doi.org/10.33371/ijoc.v12i1.548
Xu J, Lamouille S, Derynck R, "TGF-Β-induced epithelial to mesenchymal transition" Cell Research, 2009; 19(2):156-72. https://doi.org/10.1038/cr.2009.5
Dumont N, Arteaga CL, "Targeting the TGFβ signaling network in human neoplasia" Cancer Cell, 2003; 3(6):531-6. https://doi.org/10.1016/S1535-6108(03)00135-1
Sheen YY, Kim MJ, Park SA, Park SY, Nam JS, "Targeting the transforming growth factor-β signaling in cancer therapy" Biomol Ther, 2013; 21(5):323-31. https://doi.org/10.4062/biomolther.2013.072
Published



How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).